3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
25
Peritoneal Neoplasms
17
Fallopian Tube Neoplasms
11
Carcinoma, Ovarian Epithelial
6
Stomach Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Neoplasms
2
Mesothelioma
2
Hyperthermia
2
Gastrointestinal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Postoperative Complications
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Low Anterior Resection Syndrome
1
Liposarcoma
1
High Grade Serous Ovarian
1
Brenner Tumor
1
Interventions
Early Intervention, Educational
6
Oxaliplatin
5
Methods
4
Cisplatin
4
pembrolizumab
3
Trastuzumab
3
Surveys and Questionnaires
3
Specimen Handling
3
Leucovorin
3
Fluorouracil
3
Carboplatin
3
X-Rays
2
Radiotherapy
2
Observation
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Irinotecan
2
Interleukin-12 Subunit p35
2
Gemcitabine
2
Cyclophosphamide
2
Counseling
2
Cetuximab
2
Capecitabine
2
Biopsy
2
veliparib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Cytoreduction Surgical Procedures
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled